Hematology NewsPrognostic factors guide mantle cell treatment decisionsSeptember 28, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsCAR T-cell studies dominate ongoing cellular therapy trialsSeptember 26, 2018Cellular TherapyAggressive LymphomasImmuno-oncologyLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesFDA lifts partial hold on tazemetostat trialsSeptember 26, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsOutpatient lenalidomide/rituximab yields long-term MCL remissionSeptember 25, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsNICE looks likely to reject use of Kymriah for DLBCLSeptember 24, 2018Cellular TherapyBusiness of MedicineImmunotherapyPractice ManagementAggressive LymphomasB Cell Lymphoma
Hematology NewsAYA cancer: Bridging the divideSeptember 24, 2018Patient & Survivor CareB Cell Lymphoma
Hematology TimesCK and TP53 status should be assessed together, team saysSeptember 21, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaB Cell Lymphoma
Hematology TimesNICE rejects DLBCL indication for CAR T-cell therapySeptember 20, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsKymriah cost effectiveness depends on long-term outcomesSeptember 17, 2018ALLBusiness of MedicineCellular TherapyPractice ManagementImmunotherapyImmuno-oncologyB Cell Lymphoma
Hematology NewsPruritus linked to wide variety of cancersSeptember 16, 2018Indolent LymphomaAMLLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationGynecologic CancerB Cell LymphomaB Cell Lymphoma
Hematology NewsVenetoclax label now includes MRD dataSeptember 12, 2018CLLAggressive LymphomasLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology TimesMRD data added to venetoclax labelSeptember 12, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsTP53 mutation plus complex karyotype equals poor prognosisSeptember 10, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Oncology PracticeASCO updates guidance on prophylaxis for adults with cancer-related immunosuppressionSeptember 7, 2018Patient & Survivor CareIndolent LymphomaB Cell Lymphoma
